Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Growing IPF drugs market evident at ERS Congress

November 3, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ERS, Esbriet, IPF, elf, european respiratory society, ofev

Arriving in Germany for this year’s European Respiratory Society (ERS) International Congress 2014, what awaited Pharmafile at the Ausgang was …
Feature
marc_princen-

Takeda hires Merck senior head as president

November 3, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, marc princen

Marc Princen has joined Takeda Pharmaceuticals from Merck and is to serve as its corporate officer and president of the …
Appointment
Caner image

More cancer patients surviving for longer

October 31, 2014 Medical Communications, Research and Development, Sales and Marketing Cancer, bladder, breast, myeloma, oncology, ons, prostate

Cancer survival rates in England are continuing to improve, though many cancers still have an ‘extremely poor’ prognosis, according to …
News
steven_castillo

Carmago hires drug development head

October 31, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing carmago, steven castillo

US drug development firm Camargo Pharmaceutical Services has expanded its leadership team with the appointment of Steven Castillo as vice …
Appointment
richard_ransohr

Two neuroscientists join Biogen Idec

October 30, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen IDEC, richard ransohoff

Christopher Henderson and Richard Ransohoff have joined Biogen Idec to lead the company’s neurology research and discovery efforts. Henderson joins …
Appointment
Sovaldi image

Sovaldi misses estimates but still makes history

October 29, 2014 Research and Development, Sales and Marketing FDA, Gilead, harvoni, hep C, sofosbuvir, sovaldi

The trajectory of Gilead’s new hep C pill Sovaldi has slowed but the drug is still on course to break …
News
sanofi_chris_viehbacher_2

Sanofi’s chief executive ousted

October 29, 2014 Medical Communications, Research and Development, Sales and Marketing Christopher Viehbacher, Sanofi

Sanofi’s chief executive Chris Viehbacher has been ejected from his role after the French firm’s board lost patience with his …
News
Google image

Google X developing diagnosis pill

October 29, 2014 Medical Communications, Research and Development, Sales and Marketing AbbVie, Pfizer, calico, diagnosis pill, google, google x, vida, wearables

Google is developing a new pill designed to send microscopic particles into the bloodstream in an effort to identify cancers, …
News
nhs_parliament_2_8

Cancer Drugs Fund ‘papering over the cracks of a bigger issue’

October 29, 2014 Medical Communications, Research and Development, Sales and Marketing Cancer, Kadcyla, NICE, breast cancer, reform

Breakthrough Breast Cancer has raised concerns to the government this week over the ever-increasing price of new oncology medicines. Over …
News
alison_doering

Quantum promotes senior head

October 29, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alison Doering, quantam pharmaceutical

Alison Doering has been promoted to head of group marketing and communications at medicines manufacturing firm Quantum Pharmaceutical.  Doering will …
Appointment
peter_finan

Karus Therapeutics appoints two heads

October 28, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Peter Finan, Simon Roitt, karus

UK drug development firm Karus Therapeutics has grown its R&D team via two new appointments in Dr Simon Roitt, who …
Appointment
Celgene image

Celgene expands immunotherapy pipeline with Sutro

October 27, 2014 Research and Development, Sales and Marketing Celgene, PD-1 and PD-L1, Q3, oncology, sutro

Celgene has extended its collaboration with Sutro Biopharma and added a buyout option for the firm as the two companies …
News

France Focus: Power without responsibility?

October 27, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing France, Lantus, Sanofi, Servier, hollande, perindopril, report

Population: 65.8 million (2013) Government: Unitary semi-presidential constitutional republic Leader: François Hollande of the centre-left Socialist Party Gross Domestic Product: …
Feature
perez

Cubist Pharmaceuticals names chief executive

October 27, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cubist, perez

US biopharma firm Cubist Pharmaceuticals has named Robert Perez as its chief executive and who will begin the role from …
Appointment
prof_paul_workman

Cancer drug discovery system ‘broken’

October 24, 2014 Research and Development, Sales and Marketing Cancer, cancer research, oncology, paul workman

The global system for discovering new cancer drugs is ‘broken’ and failing to turn scientific advances into enough innovative new …
News
The Gateway to Local Adoption Series

Latest content

SAH Diagnostics opens new diagnostics centre in Bristol

March 30, 2026

Abselion appoints Dale Gordon as Chair

March 30, 2026

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026